MD
Medartis Holding AG
MDRSF · OTC
$115.00 +0.00% (+$0.00)
Market Cap CHF 1.18B
P/E Ratio 140.75x
Div. Yield -
ROE 3.07%
Bulios Fair Price
$165.65
44.0% upside
Current Price
$115
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MDRSF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
17 /100
Expensive P/E 140.75x
EV/EBITDA 28.43x
P/S 4.36x
Growth
75 /100
Growing Rev. growth 13.77%
Book val. growth 5.08%
EPS growth N/A
Profitability
35 /100
Moderate Gross margin 75.89%
Net margin 3.10%
Op. margin 0.72%
Quality
12 /100
Poor ROIC 0.28%
ROE 3.07%
ROA 1.49%
Debt
61 /100
Moderate Debt/Equity 0.57x
Current ratio 2.21x
Int. coverage 2.71x
Stability
54 /100
Moderate Beta 1.17x
Rev. volatility 7.08%
EPS volatility 163.28%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MDRSF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Matthias Schupp
Employees
1,337
Headquarters
Basel
Upcoming events
02 MAR
Earnings
Upcoming earnings report